Business Combinations - Summary of Activities Within Account Balance (Detail) - scPharma - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended |
|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2026 |
|
| Business Combination, Contingent Consideration [Line Items] | ||
| Beginning balance | $ 26,246 | |
| Fair value changes | $ 10,700 | 18,514 |
| Payment related to achievement of Milestone 1 | (44,760) | |
| Ending balance | $ 0 | $ 0 |
| X | ||||||||||
- Definition Business combination contingent consideration arrangements payment related to achievement of milestone 1 No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|